The Department of Health is seeking consumer representation for eight Prostheses Clinical Advisory Groups.


The Prostheses List Advisory Committee (PLAC) advises the Minister on the suitability to list on the Prostheses List under the Private Health Insurance Act 2007. The Prostheses List Clinical Advisory Groups (CAGs) are expert sub-committees of the Prostheses List Advisory Committee (PLAC) providing advice on issues relating to the clinical effectiveness of prostheses, including effectiveness compared to other devices. The PLAC makes recommendations to the Minister on which products are listed on the Prostheses List. Listing on the Prostheses List affects whether or not a prostheses benefit is available to consumers from a private health insurer.


Consumer Opportunity

Nominations/renominations are now due for the following Clinical Advisory Groups:

  • Prostheses Clinical Advisory Group – Specialist Orthopaedic
  • Prostheses Clinical Advisory Group – Cardiac
  • Prostheses Clinical Advisory Group – Cardiothoracic
  • Prostheses Clinical Advisory Group – Ophthalmic
  • Prostheses Clinical Advisory Group – Orthopaedic (Hips)
  • Prostheses Clinical Advisory Group – Orthopaedic (Knees – KPCAG)
  • Prostheses Clinical Advisory Group – Spinal
  • Prostheses Clinical Advisory Group – Vascular Stents and Grafts

The CAGs refer applications to the Medical Services Advisory Committee (MSAC) where the:

  • New medical device employs a medical service that is not currently covered in the Medicare Benefits Schedule (MBS), or
  • New medical device might be used in a medical service that is currently described in the MBS, but potentially extends the range of indications/patients beyond the original intent of the MBS item/s.

The CAGs also advise the PLAC on:

  • The evidence and information they require to assess applications to list medical devices on the Prostheses List.
  • Any concerns in relation to safety and/or performance of medical devices, for referral to the Therapeutic Goods Administration.
  • Reviewing the listing of medical devices in view of issues relating to comparative health outcomes.
  • On any other matter, as required.

More information is available HERE


The workload for this work consists of four meetings per year over a four year term. Meetings will be a combination of face to face and teleconference meetings. Please note that the Department of Health will cover sitting fees and travel costs for this work.

How to Apply

  • CHF invites expressions of interest from consumer representatives by midnight AEST on Sunday 16 September 2018. Interested consumer representatives will need to:
  • Complete a CHF nomination form available online
  • Attach a letter of endorsement from a supporting health consumer organisation and/or provide sound demonstration of your links with a consumer base. This information ensures that consumer representatives are accountable to consumers. Please note that the health consumer group need not be a CHF member. This process ensures consumer representatives are placed with the confidence of consumers and have in place a consultative base enabling reps to draw from and report to consumers.
  • Attach a short CV in pdf format

Please contact Ghislaine Martin on 02 6273 5444 or via email at [email protected] should you have any queries.

Expressions of interest close at midnight AEST 16 September 2018